CMRonc
journal
Dear colleagues,
You are invited to submit your next article on oncology to this journal. While offering all the other benefits Libertas Academica's open access journals, this is a restricted access journal offering pay-per-view or subscription access only. As such it is an excellent destination for authors who require fast, friendly, service, high visibility and objective peer review but do not want their article to be freely available to all internet users.
Advantages of Publishing
Visibility: high on-website open access visibility
Speed: just 21 days average to first editorial decision including two high-quality peer reviews
Service: accessible professional staff
Author rewards: submit more than one paper over 365 days and high-priority processing and production and progressively higher levels of article processing fee discount
What Do Your Colleagues Say?
"I had an excellent experience publishing our review article in Clinical Medicine Reviews. The managing editor was very helpful and the process was very timely and transparent." -Professor Jonathan A. Bernstein. More testimonials...
Read more about preparing your manuscript for submission and watch a video on how to submit it.
Yours sincerely,
Dr Garry Walsh
Editor in Chief
My recent paper in Clinical Medicine Insights: Therapeutics was the third I have published in a Libertas Academica journal. Again, I was very pleased by the remarkable speed of publication. It took less than seven weeks from submission of the first manuscript version and two weeks from submission of the revision to the appearance of the final article. When I had unforeseen problems with the transmission of proof corrections because of some software incompatibilities the production team acted immediately and was very helpful. Over 300 views in less than 3 weeks after publication indicate excellent visibility of the article and of the journal too. Congratulations!Dr Ruediger Hardeland (University of Goettingen, Germany) What Your Colleagues Say
Copyright © 2012 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)
FacebookGoogle+Twitter
PinterestTumblrYouTube